The full piece from Diabetologia:
https://link.springer.com/article/10.1007/s00125-021-05519-y
Intra-organ fat content during weight loss-induced remission of type 2 diabetes in people with normal or raised BMI
R. Taylor1, A.C. Barnes1, K.M. Irvine1, T.L. Kelly1, K.G. Hollingsworth1, N. Sattar2, M.E.J. Lean3, A. Al-Mrabeh1;
1Institute of Translational & Clinical Research, Newcastle University, Newcastle upon Tyne, 2Institute of Health and Wellbeing, Glasgow University, Glasgow, 3Human Nutrition, Glasgow University, Glasgow, UK.
Background and aims: The aetiology of type 2 diabetes is often assumed to be different in people who are overweight or obese compared with those with BMI in the ‘normal’ range. However, clinical observation suggested that losing body fat from above a ‘personal fat threshold’ at any BMI level can bring about remission of diabetes. We therefore compared baseline liver and pancreas fat content in people with type 2 diabetes and BMI above or below 27kg/m2 and examined changes in intra-organ fat after weight loss in relation to remission of diabetes in each group.
Materials and methods: We examined data from two cohorts (DiRECT: BMI 35.1±4.5 kg/m2; n=56, age 53.3±7.6 years, diabetes duration 3.0±1.7years; ReTUNE: BMI 24.3±2.0kg/m2, n=17, age 58.2±7.3 years, diabetes duration 2.6±2.2 years). Age, sex and BMI-matched control groups without diabetes were also studied (BMI>27kg/m2: n=18, age 55.4±6.0 years; BMI<27kg/m2: n=11, age 58.8±9.5 years). Weight loss was achieved using a low calorie diet (~800 kcal/day) followed by food reintroduction and weight maintenance. In those with BMI<27kg/m2, other types of diabetes identified by antibody and genetic tests (n=2: 1 T1DM, 1 MODY) were excluded from analysis. Intra-organ fat was quantified by 3-point Dixon magnetic resonance.
Results: In each BMI category, liver and intrapancreatic fat content were higher in diabetes compared with non-diabetic controls. For BMI>27kg/m2: liver fat was 16±1.3 vs. 5.5±1.4% p<0.0001 for type 2 diabetes vs. control respectively, and intrapancreatic fat 8.5±0.3 vs. 6.8±0.5% p<0.010, respectively. For BMI<27kg/m2: liver fat was 4.7±0.8 vs. 1.9±0.3% p=0.016 for type 2 diabetes vs. control, and intrapancreatic fat 5.0±0.3 vs. 3.4±1.1%, p=0.029, respectively. Both diabetic and control groups with BMI >27kg/m2 had significantly higher liver and intrapancreatic fat than those with <27kg/m2 (p<0.0001). After weight loss, liver fat content fell significantly in both groups (BMI>27kg/m2: to 3.0 ±0.5%, p<0.0001; BMI<27: to 1.4±0.1%, p=0.004). Similarly, intrapancreatic fat decreased (BMI>27- to 7.6±0.3%, p<0.0001; BMI <27 to 4.5±0.6%, p=0.026). Diabetes remissions were similar between BMI groups (60% and 67%).
Conclusion: Intra-organ fat content is elevated in people with type 2 diabetes at any level of BMI. Irrespective of BMI, 10-15% weight loss decreased liver and intrapancreatic fat with notably similar rates of remission of type 2 diabetes, consistent with the twin cycle hypothesis. Lesser elevation of liver fat, below the diagnostic threshold for NAFLD, can cause metabolic problems in leaner individuals, indicating the need to develop BMI-specific normal ranges. Across the range of BMIs, early type 2 diabetes has the same reversible pathophysiology.
Clinical Trial Registration Number: ISRCTN15177113
Supported by: We are grateful to Diabetes UK for grant funding
Disclosure: R. Taylor: Grants; Supported by grants from Diabetes UK. Lecture/other fees; academic lectures funded by Novo Nordisk, Lilly and Janssen. Non-financial support; RT is author of book 'Life Without Diabetes'.